159 related articles for article (PubMed ID: 12546279)
1. Effect of mild hypoinsulinemia on renal hypertrophy: growth hormone/insulin-like growth factor I system in mild streptozotocin diabetes.
Khamaisi M; Flyvbjerg A; Haramati Z; Raz G; Wexler ID; Raz I
Int J Exp Diabetes Res; 2002; 3(4):257-64. PubMed ID: 12546279
[TBL] [Abstract][Full Text] [Related]
2. Octreotide prevents the early increase in renal insulin-like growth factor binding protein 1 in streptozotocin diabetic rats.
Raz I; Rubinger D; Popovtzer M; Grønbaek H; Weiss O; Flyvbjerg A
Diabetes; 1998 Jun; 47(6):924-30. PubMed ID: 9604870
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of a growth hormone receptor antagonist (G120K-PEG) on renal enlargement, glomerular hypertrophy, and urinary albumin excretion in experimental diabetes in mice.
Flyvbjerg A; Bennett WF; Rasch R; Kopchick JJ; Scarlett JA
Diabetes; 1999 Feb; 48(2):377-82. PubMed ID: 10334317
[TBL] [Abstract][Full Text] [Related]
4. Expression of insulin-like growth factor binding proteins in the rat kidney: effects of long-term diabetes.
Landau D; Chin E; Bondy C; Domene H; Roberts CT; Gronbaek H; Flyvbjerg A; LeRoith D
Endocrinology; 1995 May; 136(5):1835-42. PubMed ID: 7536658
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of insulin-like growth factor-I and insulin-like growth factor binding protein-1 in the diabetic rat.
Luo JM; Murphy LJ
Mol Cell Biochem; 1991 Apr; 103(1):41-50. PubMed ID: 1713293
[TBL] [Abstract][Full Text] [Related]
6. Effects of glucocorticoids on circulating levels and hepatic expression of insulin-like growth factor (IGF)-binding proteins and IGF-I in the adrenalectomized streptozotocin-diabetic rat.
Unterman TG; Jentel JJ; Oehler DT; Lacson RG; Hofert JF
Endocrinology; 1993 Dec; 133(6):2531-9. PubMed ID: 7694841
[TBL] [Abstract][Full Text] [Related]
7. Preferential expression of insulin-like growth factor binding proteins-1, -3, and -5 during early diabetic renal hypertrophy in rats.
Park IS; Kiyomoto H; Alvarez F; Xu YC; Abboud HE; Abboud SL
Am J Kidney Dis; 1998 Dec; 32(6):1000-10. PubMed ID: 9856516
[TBL] [Abstract][Full Text] [Related]
8. Possible involvement of IGF-1 receptor and IGF-binding protein in insulin-induced enhancement of noradrenaline response in diabetic rat aorta.
Kobayashi T; Kaneda A; Kamata K
Br J Pharmacol; 2003 Sep; 140(2):285-94. PubMed ID: 12970107
[TBL] [Abstract][Full Text] [Related]
9. Effects of undernutrition and diabetes on serum and liver mRNA expression of IGFs and their binding proteins during rat development.
Rivero F; Goya L; Aláez C; Pascual-Leone AM
J Endocrinol; 1995 Jun; 145(3):427-40. PubMed ID: 7543553
[TBL] [Abstract][Full Text] [Related]
10. Corticosterone regulation of insulin-like growth factor I, IGF-binding proteins, and growth in streptozotocin-induced diabetic rats.
Rodgers BD; Strack AM; Dallman MF; Hwa L; Nicoll CS
Diabetes; 1995 Dec; 44(12):1420-5. PubMed ID: 7589849
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of thyroid hormone action on the insulin-like growth factor system: all thyroid hormone effects are not growth hormone mediated.
Näntö-Salonen K; Muller HL; Hoffman AR; Vu TH; Rosenfeld RG
Endocrinology; 1993 Feb; 132(2):781-8. PubMed ID: 7678799
[TBL] [Abstract][Full Text] [Related]
12. Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects.
Bang P; Brismar K; Rosenfeld RG; Hall K
J Clin Endocrinol Metab; 1994 Apr; 78(4):960-7. PubMed ID: 7512573
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.
Jehle PM; Jehle DR; Mohan S; Böhm BO
J Endocrinol; 1998 Nov; 159(2):297-306. PubMed ID: 9795371
[TBL] [Abstract][Full Text] [Related]
14. IGF-I and IGF-binding protein-3 in plasma of GH-deficient rats.
Butler AA; Gallaher BW; Ambler GR; Gluckman PD; Breier BH
J Endocrinol; 1996 Jul; 150(1):67-76. PubMed ID: 8708564
[TBL] [Abstract][Full Text] [Related]
15. Regional changes in the intrarenal insulin-like growth factor-I axis in diabetes.
Fervenza FC; Tsao T; Hoffman AR; Rabkin R
Kidney Int; 1997 Mar; 51(3):811-8. PubMed ID: 9067915
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factors and binding proteins in patients with recent-onset type 1 (insulin-dependent) diabetes mellitus: influence of diabetes control and intraportal insulin infusion.
Shishko PI; Dreval AV; Abugova IA; Zajarny IU; Goncharov VC
Diabetes Res Clin Pract; 1994 Aug; 25(1):1-12. PubMed ID: 7530621
[TBL] [Abstract][Full Text] [Related]
17. Tissue-specific regulation of insulin-like growth factors and insulin-like growth factor binding proteins in male diabetic rats in vivo and in vitro.
Han HJ; Kang CW; Park SH
Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1172-9. PubMed ID: 17184497
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of octreotide on renal and glomerular growth in early experimental diabetes in mice.
Grønbaek H; Nielsen B; Schrijvers B; Vogel I; Rasch R; Flyvbjerg A
J Endocrinol; 2002 Mar; 172(3):637-43. PubMed ID: 11874712
[TBL] [Abstract][Full Text] [Related]
19. Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes.
Frystyk J; Skjaerbaek C; Vestbo E; Fisker S; Orskov H
Diabetes Metab Res Rev; 1999; 15(5):314-22. PubMed ID: 10585616
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
